Depression is a widespread and debilitating mental disorder that touches the lives of millions of people worldwide. It presents significant challenges for individuals, families, and healthcare providers. While traditional therapies like medication and psychotherapy have shown effectiveness, they come with drawbacks such as treatment resistance, side effects, and access limitations. This article examines the role of artificial intelligence (AI) in diagnosing, treating, and managing depression, emphasizing its potential to enhance therapeutic outcomes and improve access to care. AI technologies, such as machine learning algorithms, natural language processing, and data analytics, open new exciting possibilities for understanding the neurobiological and psychological factors involved in depression. Furthermore, AI can be used to create personalized treatment plans, enhancing the accuracy of interventions and overcoming the limitations of one-size-fits-all approaches. Through digital platforms and mobile tools, AI can monitor patient progress and make real-time adjustments to treatment plans, improving adherence. AI-powered tools, such as chatbots and virtual therapists, are becoming valuable complements to traditional treatments, offering continuous support and reducing the burden on mental health professionals. With its ability to process vast amounts of data, AI can reveal new insights into the complex causes of depression and identify innovative therapeutic targets. However, the integration of AI into clinical practice raises significant ethical concerns, including privacy issues, algorithmic bias, and the need for robust regulation. In conclusion, while AI holds great promise for transforming depression care, further research is necessary to address its efficacy, ethical implications, and long-term impact on mental health treatment.
Masoumi et al. (Wed,) studied this question.